AEYE-DS Clinical Trials Published: First Fully Autonomous Diabetic Retinopathy Screening Technology Across Portable and Tabletop Devices Demonstrates 99% Imageability, One-Image-per-Eye Workflow, and Best-in-Class Diagnostic Efficacy

AEYE-DS Clinical Trials Published: First Fully Autonomous Diabetic Retinopathy Screening Technology Across Portable and Tabletop Devices Demonstrates 99% Imageability, One-Image-per-Eye Workflow, and Best-in-Class Diagnostic Efficacy

The pivotal trial results prove AEYE Health's FDA-cleared AI achieves >99% imageability and unmatched diagnostic accuracy using just a single image per eye, with both portable and tabletop devices, powering the industry's first practical fully autonomous diabetic eye exam screening…